首页
OALib 期刊
快速投稿通道
我的图书馆
常见问题
关于我们
关注我们+
Biomedical & Life Sciences
Business & Economics
Chemistry & Materials Science
Computer Science & Communications
Engineering
Medicine & Healthcare
Physics & Mathematics
Social Sciences & Humanities
Biomedical & Life Sciences
Business & Economics
Chemistry & Materials Science
Computer Science & Communications
Engineering
Medicine & Healthcare
Physics & Mathematics
Social Sciences & Humanities
LinkedIn (OALib Group)
LinkedIn (OALib Company Page)
Facebook
Twitter
全部
标题
作者
关键词
摘要
OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件
为什么选择我们？
>>
- 开源期刊
- 同行审议
- 快速出刊
- 终身存储
- 免费检索
- 免费推广
- 更多...
- 搜索引擎
-
ISSN Print: 1476-5608
ISSN Online:
主页:
https://www.nature.com/pcan
分享:
Go
A lifestyle intervention of weight loss via a low-carbohydrate diet plus walking to reduce metabolic disturbances caused by androgen deprivation therapy among prostate cancer patients: carbohydrate and prostate study 1 (CAPS1) randomized controlled trial
The anticancer potential of metformin on prostate cancer
Association of prostate cancer SLCO gene expression with Gleason grade and alterations following androgen deprivation therapy
Prediction of extraprostatic extension by MRI tumor contact length: difference between anterior and posterior prostate cancer
Exploring the risk-reward balance in focal therapy for prostate cancer—a contribution to the debate
Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)
Efficacy and safety of enucleation vs. resection of prostate for treatment of benign prostatic hyperplasia: a meta-analysis of randomized controlled trials
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer
Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancer
Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC)
Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care
Prostate cancer in the medicare shared savings program: are Accountable Care Organizations associated with reduced expenditures for men with prostate cancer?
Dietary inflammatory index (DII) and risk of prostate cancer in a case–control study among Black and White US Veteran men
Prolonged PSA stabilization and overall survival following sipuleucel-T monotherapy in metastatic castration-resistant prostate cancer patients
Assessing the relationship between statin use and oncologic outcomes among men electing active surveillance for localized prostate cancer
Stroke and thromboembolic events in men with prostate cancer treated with definitive radiation therapy with or without androgen deprivation therapy
Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer
Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials
SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomy
A predictive model based on biparametric magnetic resonance imaging and clinical parameters for improved risk assessment and selection of biopsy-na？ve men for prostate biopsies
Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate
Approaches to urinary detection of prostate cancer
Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry
Utility after robot-assisted radical prostatectomy compared to conventional approaches for localized prostate cancer [socioeconomic perspective study]
Prospective examination of the changes in the urinary microbiome induced by transrectal biopsy of the prostate using 16S rRNA gene analysis
Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer
Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases
Total nut, tree nut, peanut, and peanut butter intake and the risk of prostate cancer in the Netherlands Cohort Study
Allopurinol and the risk of prostate cancer in a Finnish population-based cohort
Characterizing the learning curve of MRI-US fusion prostate biopsies
Preoperative staging using magnetic resonance imaging and risk of positive surgical margins after prostate-cancer surgery
Role of multiparametric magnetic resonance imaging for patients under active surveillance for prostate cancer: a systematic review with diagnostic meta-analysis
Effect of early salvage radiotherapy at PSA？<？0.5？ng/ml and impact of post-SRT PSA nadir in post-prostatectomy recurrent prostate cancer
Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors
Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer
Estrogens and prostate cancer
Impact of age on exposure to oral antiandrogen therapies in clinical practice
Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy
Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study
Comparison of biparametric MRI to full multiparametric MRI for detection of clinically significant prostate cancer
Quantification of bone flare on 18F-NaF PET/CT in metastatic castration-resistant prostate cancer
Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population
Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance
PTEN status assessment in the Johns Hopkins active surveillance cohort
Nutrition care guidelines for men with prostate cancer undergoing androgen deprivation therapy: do we have enough evidence?
Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series
The impact of surgical duration on complications after transurethral resection of the prostate: an analysis of NSQIP data
Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer
Single-nucleotide polymorphisms in DNMT3B gene and DNMT3B mRNA expression in association with prostate cancer mortality
Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancer
Go
